文献速递产科母胎医学

在2019冠状病毒病(COVID-19)大流行早期分娩与严重孕产妇发病率之间的关联

Association Between Giving Birth During the Early Coronavirus Disease 2019 (COVID-19) Pandemic and Serious Maternal Morbidity.
PubMed 文献 · Obstet Gynecol · 2022-10-27

这项在美国17家医院开展的多中心回顾性队列研究,比较了2020年COVID-19大流行早期与2019年历史对照期分娩者的严重孕产妇发病率。结果显示,大流行期间分娩与主要复合结局(9.3% vs 8.9%,aRR 1.02,95% CI 0.93-1.11)或剖宫产(32.4% vs 31.3%,aRR 1.02,95% CI 0.97-1.07)的变化均无关,未观察到孕产妇死亡。

要点

  • 大流行期间分娩的主要复合结局发生率为9.3%,历史对照期为8.9%,aRR 1.02(95% CI 0.93-1.11)。
  • 大流行期间剖宫产率为32.4%,历史对照期为31.3%,aRR 1.02(95% CI 0.97-1.07)。
  • 尽管医院、医疗系统和社区采取了大量防疫调整措施,常见产科并发症导致的严重孕产妇发病率未升高。

核心结论

  • 尽管医院、医疗系统和社区进行了大量调整,在COVID-19大流行早期分娩与常见产科并发症导致的严重孕产妇发病率升高无关。

研究设计与样本

  • 多中心回顾性队列研究,由经过集中培训和认证的研究人员在美国17家医院手工提取病历资料。
  • 比较了在2019年(大流行前)和2020年(大流行期间)随机选取日期分娩的个体。
  • 大流行期间分娩者12,133例,大流行前分娩者9,709例。

主要发现

  • 大流行期间分娩者中,3%在孕期至产后42天期间SARS-CoV-2检测结果呈阳性。
  • 主要复合结局(孕产妇死亡或常见产科并发症导致的严重疾病)发生率:大流行期间9.3% vs 大流行前8.9%,aRR 1.02(95% CI 0.93-1.11)。
  • 剖宫产率:大流行期间32.4% vs 大流行前31.3%,aRR 1.02(95% CI 0.97-1.07)。
  • 未观察到孕产妇死亡。

关键数值与推荐

  • 主要结局为复合结局,包括孕产妇死亡或常见产科并发症导致的严重疾病:妊娠期高血压疾病(子痫、终末器官功能障碍或需要急性降压治疗)、产后出血(手术干预或接受4个单位及以上血制品)以及非SARS-CoV-2感染(脓毒症、盆腔脓肿、延长静脉抗生素使用、菌血症、深部手术部位感染)。
  • 主要次要结局为剖宫产。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether delivering during the early the coronavirus disease 2019 (COVID-19) pandemic was associated with increased risk of maternal death or serious morbidity from common obstetric complications compared with a historical control period. METHODS: This was a multicenter retrospective cohort study with manual medical-record abstraction performed by centrally trained and certified research personnel at 17 U.S. hospitals. Individuals who gave birth on randomly selected dates in 2019 (before the pandemic) and 2020 (during the pandemic) were compared. Hospital, health care system, and community risk-mitigation strategies for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in response to the early COVID-19 pandemic are described. The primary outcome was a composite of maternal death or serious morbidity from common obstetric complications, including hypertensive disorders of pregnancy (eclampsia, end organ dysfunction, or need for acute antihypertensive therapy), postpartum hemorrhage (operative intervention or receipt of 4 or more units blood products), and infections other than SARS-CoV-2 (sepsis, pelvic abscess, prolonged intravenous antibiotics, bacteremia, deep surgical site infection). The major secondary outcome was cesarean birth. RESULTS: Overall, 12,133 patients giving birth during and 9,709 before the pandemic were included. Hospital, health care system, and community SARS-CoV-2 mitigation strategies were employed at all sites for a portion of 2020, with a peak in modifications from March to June 2020. Of patients delivering during the pandemic, 3% had a positive SARS-CoV-2 test result during pregnancy through 42 days postpartum. Giving birth during the pandemic was not associated with a change in the frequency of the primary composite outcome (9.3% vs 8.9%, adjusted relative risk [aRR] 1.02, 95% CI 0.93-1.11) or cesarean birth (32.4% vs 31.3%, aRR 1.02, 95% CI 0.97-1.07). No maternal deaths were observed. CONCLUSION: Despite substantial hospital, health care, and community modifications, giving birth during the early COVID-19 pandemic was not associated with higher rates of serious maternal morbidity from common obstetric complications. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT04519502.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Metz TD, Clifton RG, Hughes BL, et al. Association Between Giving Birth During the Early Coronavirus Disease 2019 (COVID-19) Pandemic and Serious Maternal Morbidity. Obstet Gynecol. 2022. PMID: 36357949. doi:10.1097/AOG.0000000000004982

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。